Ameriprise’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $66.5M | Sell |
|
|||||
|
2025
Q2 | $119M | Sell |
|
|||||
|
2025
Q1 | $297M | Sell |
|
|||||
|
2024
Q4 | $296M | Buy |
|
|||||
|
2024
Q3 | $301M | Sell |
|
|||||
|
2024
Q2 | $387M | Sell |
|
|||||
|
2024
Q1 | $472M | Sell |
|
|||||
|
2023
Q4 | $523M | Buy |
|
|||||
|
2023
Q3 | $457M | Buy |
|
|||||
|
2023
Q2 | $424M | Sell |
|
|||||
|
2023
Q1 | $480M | Buy |
|
|||||
|
2022
Q4 | $481M | Sell |
|
|||||
|
2022
Q3 | $483M | Sell |
|
|||||
|
2022
Q2 | $482M | Buy |
|
|||||
|
2022
Q1 | $412M | Sell |
|
|||||
|
2021
Q4 | $579M | Sell |
|
|||||
|
2021
Q3 | $528M | Buy |
|
|||||
|
2021
Q2 | $547M | Buy |
|
|||||
|
2021
Q1 | $471M | Buy |
|
|||||
|
2020
Q4 | $382M | Buy |
|
|||||
|
2020
Q3 | $229M | Sell |
|
|||||
|
2020
Q2 | $387M | Buy |
|
|||||
|
2020
Q1 | $253M | Sell |
|
|||||
|
2019
Q4 | $270M | Buy |
|
|||||
|
2019
Q3 | $195M | Buy |
|
|||||
|
2019
Q2 | $247M | Buy |
|
|||||
|
2019
Q1 | $236M | Sell |
|
|||||
|
2018
Q4 | $227M | Sell |
|
|||||
|
2018
Q3 | $266M | Buy |
|
|||||
|
2018
Q2 | $229M | Buy |
|
|||||
|
2018
Q1 | $67.8M | Sell |
|
|||||
|
2017
Q4 | $93.8M | Buy |
|
|||||
|
2017
Q3 | $90.3M | Buy |
|
|||||
|
2017
Q2 | $84.9M | Sell |
|
|||||
|
2017
Q1 | $141M | Buy |
|
|||||
|
2016
Q4 | $130M | Buy |
|
|||||
|
2016
Q3 | $140M | Buy |
|
|||||
|
2016
Q2 | $115M | Buy |
|
|||||
|
2016
Q1 | $108M | Buy |
|
|||||
|
2015
Q4 | $102M | Buy |
|
|||||
|
2015
Q3 | $68.4M | Sell |
|
|||||
|
2015
Q2 | $117M | Sell |
|
|||||
|
2015
Q1 | $110M | Buy |
|
|||||
|
2014
Q4 | $65.8M | Buy |
|
|||||
|
2014
Q3 | $24.3M | Sell |
|
|||||
|
2014
Q2 | $35.2M | Sell |
|
|||||
|
2014
Q1 | $80.1M | Buy |
|
|||||
|
2013
Q4 | $64.2M | Buy |
|
|||||
|
2013
Q3 | $55.1M | Sell |
|
|||||
|
2013
Q2 | $44.9M | Buy |
|